HIV Point-of-care Testing Market Size, Share, Growth, Forecast, Analysis | Valuates Reports

HIV Point-of-Care Testing Market Statistics 2028

Due to the COVID-19 pandemic, the global HIV Point-of-care Testing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Testing Equipment accounting for % of the HIV Point-of-care Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period. China HIV Point-of-care Testing market size is valued at US$ million in 2021, while the US and Europe HIV Point-of-care Testing are US$ million and US$ million, severally.

The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe HIV Point-of-care Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of HIV Point-of-care Testing include Abbott, BD, Biomerieux, Adaltis and Roche, etc. In 2021, the global top five players have a share of approximately % in terms of revenue. HIV Point-of-care Testing is used to screen HIV antibodies. They can be performed in hospitals, clinics, and home care settings, and the results of these tests are available within a few minutes.

HIV Point-of-Care Testing Market Segments

HIV Point-of-care Testing market is segmented by Type and by Application. Players, stakeholders, and other participants in the global HIV Point-of-care Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Download Free Sample: https://reports.valuates.com/market-reports/QYRE-Auto-33A866/global-hiv-point-of-care-testing

Segment By Type
• Testing Equipment
• Testing Reagent

Segment By Application
• Hospitals
• Clinics
• Home Care Setting

Segment By Company
• Abbott
• BD
• Biomerieux
• Adaltis
• Roche

Segment By Region
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Russia
• Asia-Pacific
o China
o Japan
o South Korea
o India
o Australia
o Taiwan
o Indonesia
o Thailand
o Malaysia
o Philippines
o Vietnam
• Latin America
o Mexico
o Brazil
o Argentina
• Middle East & Africa
o Turkey
o Saudi Arabia
o U.A.E

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-33A866/global-hiv-point-of-care-testing

Similar Reports:

1. HIV Therapeutics Market: https://reports.valuates.com/market-reports/QYRE-Auto-22W5974/global-hiv-therapeutics

2. HIV, HBV and HCV Test Kits Market : https://reports.valuates.com/market-reports/QYRE-Auto-32Z9706/global-hiv-hbv-and-hcv-test-kits

3. HIV Diagnosis Market : https://reports.valuates.com/market-reports/QYRE-Auto-22D2621/global-hiv-diagnosis

4. HIV-AIDS Testing Market : https://reports.valuates.com/market-reports/QYRE-Auto-19E6138/global-hiv-aids-testing

5. Artificial Intelligence (AI) in HIV and AIDS Market : https://reports.valuates.com/market-reports/QYRE-Auto-5G10088/global-artificial-intelligence-ai-in-hiv-and-aids

https://reports.valuates.com/sitemap/html/reports/119
https://reports.valuates.com/sitemap/html/reports/120
https://reports.valuates.com/sitemap/html/reports/120

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.